Susquehanna International Group’s Immune Design Corp. IMDZ Stock Holding History

Susquehanna International Group’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-35,287	Closed	-$120K	–	10633
2018 Q4	$45K	Buy	+35,287	New	+$61.3K	﹤0.01%	8523
2018 Q2	–	Sell	-51,654	Closed	-$206K	–	11057
2018 Q1	$170K	Buy	51,654 +23,422	+83%	+$82.9K	﹤0.01%	8448
2017 Q4	$110K	Buy	+28,232	New	+$154K	﹤0.01%	8653
2017 Q2	–	Sell	-21,119	Closed	-$144K	–	10461
2017 Q1	$144K	Sell	21,119 -3,199	-13%	-$18.5K	﹤0.01%	8227
2016 Q4	$134K	Buy	+24,318	New	+$172K	﹤0.01%	8932

Susquehanna International Group's IMDZ Position: Q1 2019 in Review

Susquehanna International Group sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 35,287 shares — an estimated $120K sold.

Susquehanna International Group first reported a position in IMDZ in Q4 2016 and held it in 5 quarters. The position peaked at $170K in Q1 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

Susquehanna International Group reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
Susquehanna International Group sold 35,287 Immune Design Corp. shares in Q1 2019, an estimated $120K.
Susquehanna International Group first reported a position in Immune Design Corp. in Q4 2016 and held it in 5 quarters.
Susquehanna International Group's Immune Design Corp. position peaked at $170K in Q1 2018.
68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.